Healx
Contact us
We understand the urgency of accessing treatments for rare diseases and kindly ask that you review our Compassionate Use Policy for details of our process and how to submit a request
Latest news and articles
News & Opinion
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
In the media
Tim Guilliams talks about Using AI to De-Risk Rare Disease Drug Development
News & Opinion
Jonathan Milner, Ph.D., Appointed as Non-Executive Chairman of Healx